$ELIQQ
Electriq Power Holdings, Inc.

2023 Q3 Form 10-Q Financial Statement

#000119312523209207 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $834.3K $0.00
YoY Change
Cost Of Revenue $853.6K $394.2K
YoY Change -84.82%
Gross Profit -$19.35K -$350.5K
YoY Change -105.28%
Gross Profit Margin -2.32%
Selling, General & Admin $6.116M $1.740M
YoY Change 249.91% 1017.17%
% of Gross Profit
Research & Development $1.012M $1.067M
YoY Change 12.27%
% of Gross Profit
Depreciation & Amortization $42.49K $40.46K
YoY Change 34.98%
% of Gross Profit
Operating Expenses $7.127M $1.730M
YoY Change 307.79% 1010.75%
Operating Profit -$7.147M -$1.737M
YoY Change 308.9% 1015.46%
Interest Expense $1.292M $1.790M
YoY Change -46.35% -39.69%
% of Operating Profit
Other Income/Expense, Net $3.380M $24.63M
YoY Change -76434.46%
Pretax Income -$19.95M $1.164M
YoY Change -3122.11% -58.62%
Income Tax $0.00 $382.7K
% Of Pretax Income 32.89%
Net Earnings -$19.95M $781.1K
YoY Change -6955.28% -71.64%
Net Earnings / Revenue -2391.75%
Basic Earnings Per Share -$0.74
Diluted Earnings Per Share -$0.74 $0.06
COMMON SHARES
Basic Shares Outstanding 38.12M
Diluted Shares Outstanding 26.94M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.100M $100.0K
YoY Change 3242.86% 103.62%
Cash & Equivalents $8.100M $105.5K
Short-Term Investments
Other Short-Term Assets $990.5K $100.0K
YoY Change 139.75% -85.91%
Inventory $20.93M $14.42M
Prepaid Expenses $112.1K
Receivables $371.9K $129.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $32.49M $217.6K
YoY Change 4857.47% -71.33%
LONG-TERM ASSETS
Property, Plant & Equipment $1.731M $5.231M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $131.3K $85.10M
YoY Change -99.97% -78.76%
Total Long-Term Assets $5.209M $85.10M
YoY Change -98.7% -78.76%
TOTAL ASSETS
Total Short-Term Assets $32.49M $217.6K
Total Long-Term Assets $5.209M $85.10M
Total Assets $37.70M $85.32M
YoY Change -90.64% -78.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.201M $246.4K
YoY Change 4802.47% 5359.52%
Accrued Expenses $2.295M $6.327M
YoY Change -17.16% 290.88%
Deferred Revenue $326.0K
YoY Change
Short-Term Debt $0.00 $5.400M
YoY Change -100.0% 91.49%
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $13.45M $13.56M
YoY Change 116.4% 199.92%
LONG-TERM LIABILITIES
Long-Term Debt $21.47M $0.00
YoY Change
Other Long-Term Liabilities $2.605M $800.0K
YoY Change -82.63% -94.87%
Total Long-Term Liabilities $2.605M $800.0K
YoY Change -82.63% -94.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.45M $13.56M
Total Long-Term Liabilities $2.605M $800.0K
Total Liabilities $40.56M $14.36M
YoY Change 91.18% -28.64%
SHAREHOLDERS EQUITY
Retained Earnings -$118.5M -$12.50M
YoY Change 493.68% -33.68%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$42.38M -$12.50M
YoY Change
Total Liabilities & Shareholders Equity $37.70M $85.32M
YoY Change -90.64% -78.74%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$19.95M $781.1K
YoY Change -6955.28% -71.64%
Depreciation, Depletion And Amortization $42.49K $40.46K
YoY Change 34.98%
Cash From Operating Activities -$9.047M -$500.0K
YoY Change 7031.81% -4.28%
INVESTING ACTIVITIES
Capital Expenditures $261.0K $84.34K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.910K -$1.350M
YoY Change -100.6%
Cash From Investing Activities -$262.9K -$1.350M
YoY Change -182.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.03M 1.940M
YoY Change 288.0%
NET CHANGE
Cash From Operating Activities -9.047M -500.0K
Cash From Investing Activities -262.9K -1.350M
Cash From Financing Activities 13.03M 1.940M
Net Change In Cash 3.723M 90.00K
YoY Change 1827.19% -502.5%
FREE CASH FLOW
Cash From Operating Activities -$9.047M -$500.0K
Capital Expenditures $261.0K $84.34K
Free Cash Flow -$9.308M -$584.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001827871
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Electriq Power Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-39948
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3310839
dei Entity Address Address Line1
EntityAddressAddressLine1
625 North Flagler Drive, Suite 1003
dei Entity Address City Or Town
EntityAddressCityOrTown
West Palm Beach
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33401
dei City Area Code
CityAreaCode
833
dei Local Phone Number
LocalPhoneNumber
462-2883
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38120937
CY2023Q2 us-gaap Cash
Cash
105457
CY2022Q4 us-gaap Cash
Cash
19750
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
112099
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
108156
CY2023Q2 us-gaap Assets Current
AssetsCurrent
217556
CY2022Q4 us-gaap Assets Current
AssetsCurrent
127906
CY2023Q2 eliq Cash And Investments Held In Trust Noncurrent
CashAndInvestmentsHeldInTrustNoncurrent
85098433
CY2022Q4 eliq Cash And Investments Held In Trust Noncurrent
CashAndInvestmentsHeldInTrustNoncurrent
80945242
CY2023Q2 us-gaap Assets
Assets
85315989
CY2022Q4 us-gaap Assets
Assets
81073148
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
246388
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
276917
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6326892
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4472261
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1556523
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1055680
CY2023Q2 eliq Franchise Tax Payable Current
FranchiseTaxPayableCurrent
20050
CY2022Q4 eliq Franchise Tax Payable Current
FranchiseTaxPayableCurrent
50
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13558710
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8135278
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
800000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
800000
CY2023Q2 eliq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
0
CY2022Q4 eliq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
14000000
CY2023Q2 us-gaap Liabilities
Liabilities
14358710
CY2022Q4 us-gaap Liabilities
Liabilities
22935278
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
83461641
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79739786
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12504862
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21602916
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12504362
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-21601916
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
85315989
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81073148
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1666324
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84749
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3051026
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158982
CY2023Q2 eliq Franchise Tax Expenses
FranchiseTaxExpenses
50000
CY2022Q2 eliq Franchise Tax Expenses
FranchiseTaxExpenses
50000
eliq Franchise Tax Expenses
FranchiseTaxExpenses
100000
eliq Franchise Tax Expenses
FranchiseTaxExpenses
138844
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1737324
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-155749
us-gaap Operating Income Loss
OperatingIncomeLoss
-3193026
us-gaap Operating Income Loss
OperatingIncomeLoss
-339326
CY2023Q2 eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
1113200
CY2022Q2 eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
0
eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
1113200
eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
0
CY2023Q2 eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
-428594
CY2022Q2 eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
0
eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
-886513
eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
0
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-600000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2400000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9000000
CY2023Q2 eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
759391
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1097867
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1899383
eliq Investment Income Released From Trust Account To Pay For Taxes
InvestmentIncomeReleasedFromTrustAccountToPayForTaxes
80000
eliq Investment Income Released From Trust Account To Pay For Taxes
InvestmentIncomeReleasedFromTrustAccountToPayForTaxes
0
CY2022Q2 eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
568143
eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
1371765
eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
600790
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1163861
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2812394
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
178452
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9261464
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382744
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57686
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500843
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57686
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
781117
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2754708
us-gaap Net Income Loss
NetIncomeLoss
-322391
us-gaap Net Income Loss
NetIncomeLoss
9203778
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-21601916
CY2023Q1 eliq Increasing In Carrying Value Of Common Stock Subject To Possible Redemption
IncreasingInCarryingValueOfCommonStockSubjectToPossibleRedemption
-1874987
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1103508
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24580411
CY2023Q2 eliq Increasing In Carrying Value Of Common Stock Subject To Possible Redemption
IncreasingInCarryingValueOfCommonStockSubjectToPossibleRedemption
11294932
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
781117
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12504362
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-27941377
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
6449070
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-21492307
CY2022Q2 eliq Increasing In Carrying Value Of Common Stock Subject To Possible Redemption
IncreasingInCarryingValueOfCommonStockSubjectToPossibleRedemption
-117010
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2754708
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-18854609
us-gaap Net Income Loss
NetIncomeLoss
-322391
us-gaap Net Income Loss
NetIncomeLoss
9203778
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9000000
eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
1113200
eliq Gain On Forgiveness Of Deferred Underwriting Fee Payable
GainOnForgivenessOfDeferredUnderwritingFeePayable
0
eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
-886513
eliq Changes In Fair Value Of Working Capital Loan Related Parties
ChangesInFairValueOfWorkingCapitalLoanRelatedParties
0
eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
1371765
eliq Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
600790
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3943
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
604006
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-30529
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-44404
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2109631
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-810222
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
500843
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
57686
eliq Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
20000
eliq Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
-101425
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2861426
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2781426
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3965000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1900000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3965000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1900000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
85707
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
617
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19750
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48491
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105457
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49108
eliq Forgiveness Of Deferred Underwriting Fee Payable Allocated To Common Stock
ForgivenessOfDeferredUnderwritingFeePayableAllocatedToCommonStock
13141800
eliq Forgiveness Of Deferred Underwriting Fee Payable Allocated To Common Stock
ForgivenessOfDeferredUnderwritingFeePayableAllocatedToCommonStock
0
eliq Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022Q4 eliq Maximum Threshold Deposit In Trust Account For Extension Of Business Combination Period
MaximumThresholdDepositInTrustAccountForExtensionOfBusinessCombinationPeriod
600000
CY2022Q4 eliq Threshold Contribution Per Public Share For Extension Of Business Combination Period
ThresholdContributionPerPublicShareForExtensionOfBusinessCombinationPeriod
0.06
CY2023Q1 us-gaap Cash
Cash
476904
CY2023Q2 eliq Operating Cash In Bank
OperatingCashInBank
105457
CY2023Q2 eliq Working Capitaldeficit
WorkingCapitaldeficit
11800000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1400000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
192000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with <div style="letter-spacing: 0px; top: 0px;;display:inline;">GAAP </div>requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. </div></div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 eliq Terms Of Restricted Investments
TermsOfRestrictedInvestments
P185D
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
297000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
349000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
eliq Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo
MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo
P30D
CY2021Q1 eliq Underwriting Discount Paid Per Unit
UnderwritingDiscountPaidPerUnit
0.2
CY2021Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
8000000
CY2021Q1 eliq Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2021Q1 eliq Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
14000000
CY2023Q2 eliq Deferred Underwriting Fee
DeferredUnderwritingFee
14000000
eliq Waiver Of Deferred Underwriting Fee
WaiverOfDeferredUnderwritingFee
14000000
eliq Offering Costs Allocated To Public Warrants
OfferingCostsAllocatedToPublicWarrants
858200
eliq Underwriter Expenses
UnderwriterExpenses
255000
CY2023Q2 eliq Contingent Fee
ContingentFee
1620000
CY2022Q4 eliq Contingent Fee
ContingentFee
949000
CY2022Q3 eliq Percentage Of Federal Excise Tax On Stock Buy Back
PercentageOfFederalExciseTaxOnStockBuyBack
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 eliq Percentage Of Ownership Held By Initial Shareholders
PercentageOfOwnershipHeldByInitialShareholders
0.20
CY2023Q2 eliq Minimum Percentage Of Outstanding Shareholders Approval Required For Amendment
MinimumPercentageOfOutstandingShareholdersApprovalRequiredForAmendment
0.90
CY2023Q2 eliq Common Stock Threshold Percentage On Conversion Of Shares
CommonStockThresholdPercentageOnConversionOfShares
0.20
eliq Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo
MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo
P30D
eliq Number Of Consecutive Trading Days For Determining Share Price
NumberOfConsecutiveTradingDaysForDeterminingSharePrice
P10D

Files In Submission

Name View Source Status
0001193125-23-209207-index-headers.html Edgar Link pending
0001193125-23-209207-index.html Edgar Link pending
0001193125-23-209207.txt Edgar Link pending
0001193125-23-209207-xbrl.zip Edgar Link pending
d537235d10q.htm Edgar Link pending
d537235dex311.htm Edgar Link pending
d537235dex312.htm Edgar Link pending
d537235dex321.htm Edgar Link pending
d537235dex322.htm Edgar Link pending
eliq-20230630.xsd Edgar Link pending
d537235d10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
eliq-20230630_def.xml Edgar Link unprocessable
eliq-20230630_lab.xml Edgar Link unprocessable
eliq-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
eliq-20230630_cal.xml Edgar Link unprocessable